Together, these results represent a group of structurally related isoflavonoids with dual pharmacological properties, inhibiting MAO-B and mitigating oxidative stress, which may have therapeutic relevance in neurodegenerative disorders such as Parkinson’s disease. Here, MAOB is linked to Parkinson disease.